Market Snapshot
  • U.S.
  • Europe
  • Asia
Ticker Volume Price Price Delta
DJIA 16,408.54 -16.31 -0.10%
S&P 500 1,864.85 2.54 0.14%
NASDAQ 4,095.52 9.29 0.23%
Ticker Volume Price Price Delta
STOXX 50 3,155.81 16.55 0.53%
FTSE 100 6,625.25 41.08 0.62%
DAX 9,409.71 91.89 0.99%
Ticker Volume Price Price Delta
NIKKEI 14,516.27 98.74 0.68%
TOPIX 1,173.37 6.78 0.58%
HANG SENG 22,760.24 64.23 0.28%

Geron Corp. : Geron Announces Conference Call to Discuss First Quarter 2013 Financial Results

 Geron Corp. : Geron Announces Conference Call to Discuss First Quarter 2013
                              Financial Results

Menlo Park, Calif., April 22, 2013 - Geron Corporation (Nasdaq: GERN) will
announce its financial results for the first quarter ended March 31, 2013, on
Thursday, April 25, 2013, after the market close. Geron's management will host
a conference call for analysts and investors on Friday, April 26, 2013, at
8:30 a.m. Eastern Time to discuss the company's first quarter results and
recent events.

Participants can access the conference call live via telephone by dialing
866-953-6860 (U.S.); 617-399-3484 (international). The passcode is 44015814.
If accessing the conference call by telephone, please dial in at least 10
minutes early to minimize any delay in joining the call. A live audio-only
webcast is also available at
The audio webcast of the conference call will be available for replay
approximately one hour following the live broadcast through May 25, 2013.

About Geron

Geron is a biopharmaceutical company developing first-in-class therapies for
cancer, including its telomerase inhibitor, imetelstat, in clinical
development. For more information about Geron, visit


Anna Krassowska, Ph.D.
Investor and Media Relations



This announcement is distributed by Thomson Reuters on behalf of Thomson
Reuters clients.

The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and other
applicable laws; and
(ii) they are solely responsible for the content, accuracy and originality of
information contained therein.

Source: Geron Corp. via Thomson Reuters ONE
Sponsored Links
Sponsored Links